Possible explanations can be found not only in the immune role of the thymus and in the particular predisposition to immune paraneoplastic syndromes observed in patients with thymoma, but also in the combined effects of anti-PD-1/PD-L1 drugs on this substrate (134, 135). Here, CD274 is linked to thymoma.